EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between serum lactate dehydrogenase level and renal outcome in patients with advanced chronic kidney disease without diabetes mellitus

Yoshihiro Nakamura, Shimon Kurasawa, Takahiro Imaizumi, Terumasa Hayashi, Ichiei Narita, Kenichiro Tanabe, Satoshi Morita, Yoshiharu Tsubakihara, Enyu Imai, Tadao Akizawa, Shoichi Maruyama

Clinical and Experimental Nephrology · 2026

DOI: 10.1007/s10157-026-02855-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Nephrology, 2026. Verfasst von Yoshihiro Nakamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Aichi, Japan. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, L-Lactate Dehydrogenase, Kidney. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Translational Research Center for Medical Innovatio, Nagoya University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Higher serum lactate dehydrogenase (LDH) levels are associated with poor prognosis including renal outcome, all-cause and cardiovascular mortality in patients with diabetic kidney disease. However, this association remains unclear in patients with chronic kidney disease (CKD) without diabetes mellitus (DM).

Methods

Using data from the PREDICT trial, which enrolled patients aged 20–85 years with an estimated glomerular filtration rate (eGFR) of 8–20 mL/min/1.73 m 2 and hemoglobin

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicL-Lactate DehydrogenaseKidneyHumansAgedMaleFemaleMiddle AgedAged, 80 and overGlomerular Filtration RateBiomarkersRisk FactorsCardiovascular DiseasesAdultPrognosisTime FactorsUp-RegulationYoung Adult

Stichwörter der Autor:innen

Advanced chronic kidney diseaseCardiovascular eventsLactate dehydrogenaseRenal outcome

Substanzen

L-Lactate DehydrogenaseBiomarkers

Autor:innen und Institutionen

  • Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Aichi, Japan.
  • Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Aichi, Japan.
  • Department of Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan.
  • Division of Clinical Nephrology and Rheumatology, Niigata University, Niigata, Japan.
  • Division of Health Data Science, Translational Research Center for Medical Innovation, Kobe, Japan.
  • Pathophysiology and Bioregulation, St. Marianna University Graduate School of Medicine, Kanagawa, Japan.

Förderung

  • Translational Research Center for Medical Innovatio
  • Nagoya University

Zitieren

APA

Nakamura, Y., Kurasawa, S., Imaizumi, T., Hayashi, T., Narita, I., Tanabe, K., Morita, S., Tsubakihara, Y., Imai, E., Akizawa, T., & Maruyama, S. (2026). Association between serum lactate dehydrogenase level and renal outcome in patients with advanced chronic kidney disease without diabetes mellitus. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-026-02855-4

Vancouver

Nakamura Y, Kurasawa S, Imaizumi T, Hayashi T, Narita I, Tanabe K, et al. Association between serum lactate dehydrogenase level and renal outcome in patients with advanced chronic kidney disease without diabetes mellitus. Clinical and Experimental Nephrology. 2026. doi:10.1007/s10157-026-02855-4

BibTeX
@article{Nakamura2026,
  author = {Nakamura, Yoshihiro and Kurasawa, Shimon and Imaizumi, Takahiro and Hayashi, Terumasa and Narita, Ichiei and Tanabe, Kenichiro and Morita, Satoshi and Tsubakihara, Yoshiharu and Imai, Enyu and Akizawa, Tadao and Maruyama, Shoichi},
  title = {Association between serum lactate dehydrogenase level and renal outcome in patients with advanced chronic kidney disease without diabetes mellitus},
  journal = {Clinical and Experimental Nephrology},
  year = {2026},
  doi = {10.1007/s10157-026-02855-4}
}
Kostenlos starten →